Prevention better than treatment of heart disease in China
Cheng, T.O.
Medical Journal of Australia 154(3): 224
1991
ISSN/ISBN: 0025-729X PMID: 1988815 Document Number: 383738
Document emailed within 1 workday
Related Documents
Chen, X.; Sun, X.; Cai, G. 2014: The public healthy policy of the prevention and treatment of chronic kidney disease in China Zhonghua Yi Xue Za Zhi 94(4): 241-243Yang, W.Z. 2019: Dramatic achievements in infectious disease prevention and treatment in China during the past 70 years Zhonghua Liu Xing Bing Xue Za Zhi 40(12): 1493-1498
Zhao, S-Hua.; Hu, D-Yi. 2009: To advance the standardization and internationalization of interventional treatment of structural heart disease in China Zhonghua Xin Xue Guan Bing Za Zhi 37(11): 961-962
Liu, X.L.; Xiao, Y.L.; Tang, H.Q.; Chen, B.L.; Yang, L.H.; Xiao, Y.L.; Lv, S.J. 2018: An analysis of status of personnel in occupational disease prevention and treatment institutions in Hunan Province, China, from 1996 to 2015 Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 36(1): 32-35
Kittel, F.; Kornitzer, M.; De Backer, G.; Dramaix, M. 1982: The Belgian Heart Disease Prevention Project: type A behavior pattern and the prevalence of coronary heart disease Activitas Nervosa Superior Suppl. 3(Pt 1): 78-83
Berra, K.A.; Fair, J.M.; Houston, N. 1977: The role of physical exercise in the prevention and treatment of coronary heart disease Heart and Lung: the Journal of Critical Care 6(2): 288-292
Sorokina, E.I. 1975: Urgent problems of treatment and prevention of ischemic heart disease by means of physical factors Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 1975(2): 101-107
Martynov, A.I.; Ostroumova, O.D.; Sharif, S.F. 1998: Ischemic heart disease in the elderly and senile patients: clinical presentation, diagnosis, treatment, prevention Klinicheskaia Meditsina 76(1): 5-10
Iushkenas, I.B.; Zhemaĭtite, D.I.; Stankus, A.I. 1987: The immediate effectiveness of rehabilitative treatment and secondary prevention in ischemic heart disease patients at Palanga health resort Kardiologiia 27(9): 50-54
Yin, X-jun.; Shi, X-ming.; Si, X.; Gao, X.; Zhai, Y. 2010: Assessment of capacity for chronic noncommunicable diseases prevention and control of the Center for Disease Control and Prevention Organizations in China Zhonghua Liu Xing Bing Xue Za Zhi 31(10): 1125-1129
Kleinert, S. 1999: HOPE for cardiovascular disease prevention with ACE-inhibitor ramipril. Heart Outcomes Prevention Evaluation Lancet 354(9181): 841
Sen, S.; Sen, K.; Das, D. 2020: Differential effect of catechin hydrate and caffeine and it's metabolite on prevention of methemoglobinemia caused by nitrate and nitrite containing drugs used for the treatment of coronary heart disease Journal of the Association of Physicians of India 68(1): 105
Gohlke-Bärwolf, C.; Acar, J.; Oakley, C.; Butchart, E.; Burckhart, D.; Bodnar, E.; Hall, R.; Delahaye, J.P.; Horstkotte, D.; Krémer, R. 1995: Guidelines for prevention of thromboembolic events in valvular heart disease. Study Group of the Working Group on Valvular Heart Disease of the European Society of Cardiology European Heart Journal 16(10): 1320-1330
Jenni, D.; Osterwalder, R.; Osswald, S.; Buser, P.; Pfisterer, M. 2001: Are we treating coronary heart disease and heart failure appropriately in the clinic and ambulatory care? Secondary prevention and drug therapy 1998 Praxis 90(41): 1759-1765
Zhao, D. 2013: China guiding outline on cardiovascular disease prevention Zhonghua Xin Xue Guan Bing Za Zhi 41(7): 538-539
2018: Expert consensus on immunization for prevention of pneumococcal disease in China (2017) Zhonghua Liu Xing Bing Xue Za Zhi 39(2): 111-138
Hao, M.; Yu, J.; Yu, M.; Duan, Y. 2005: Project summarize of "reestablishing disease prevention and control system of China" Wei Sheng Yan Jiu 34(1): 2-4 9
Xie, H-Bin.; Luo, L.; Su, Z-Xin.; Wang, W-Cheng.; Wang, Y.; Sun, M.; Ma, N.; Yu, J.; Yu, M.; Duan, Y.; Gong, X.; Chen, Z.; Wang, H.; Shi, P.; Liang, Z.; Yang, F.; Wang, D.; Yue, J.; Luo, S.; Hao, M. 2005: Human resources allocation in centers of disease prevention and control in China Wei Sheng Yan Jiu 34(4): 390-392
Stamler, J. 1973: Heart disease prevention in industry. Primary prevention in mass community efforts to control the major coronary risk factors: the challenges and possibilities--critical issues and outlook for the future Journal of Occupational Medicine.: Official Publication of the Industrial Medical Association 15(1): 54-59
Zhao, D. 2013: The prevention and control of cerebrovascular disease: the key strategy to prolong the life expectancy in China Zhonghua Nei Ke Za Zhi 52(3): 179-180